Crystal structures of multidrug-resistant HIV-1 protease in complex with two potent anti-malarial compounds (original) (raw)
Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2′-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex
Klara Rombauts
Bioorganic & Medicinal Chemistry, 2003
View PDFchevron_right
Structural implications of drug-resistant mutants of HIV-1 protease: High-resolution crystal structures of the mutant protease/substrate analogue complexes
Irene Weber
Proteins: Structure, Function, and Genetics, 2001
View PDFchevron_right
INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug Design 1
Alexander Wlodawer
Annual Review of Biophysics and Biomolecular Structure, 1998
View PDFchevron_right
New Active HIV-1 Protease Inhibitors Derived from 3-Hexanol: Conformation Study of the Free Inhibitors in Crystalline State and in Complex with the Enzyme
Jindřich Hašek
Chemical Biology & Drug Design, 2012
View PDFchevron_right
Design, Synthesis, Evaluation, and Crystallographic-Based Structural Studies of HIV1 Protease Inhibitors with Reduced Response to the V82A Mutation
F. Javier Sardina
Journal of Medicinal Chemistry, 2008
View PDFchevron_right
Structure of HOE/BAY 793 Complexed to Human Immunodeficiency Virus (HIV-1) Protease in Two Different Crystal Forms Structure/Function Relationship and Influence of Crystal Packing
Juraj Sedláček, Jochen Knolle
European Journal of Biochemistry, 1997
View PDFchevron_right
Substrate shape determines specificity of recognition for HIV1 protease: analysis of crystal structures of six substrate complexes
Moses Prabu
2002
View PDFchevron_right
High Resolution Crystal Structures of HIV-1 Protease with a Potent Non-peptide Inhibitor (UIC-94017) Active Against Multi-drug-resistant Clinical Strains
Yuan-fang Wang, Irene Weber
Journal of Molecular Biology, 2004
View PDFchevron_right
Potent New Antiviral Compound Shows Similar Inhibition and Structural Interactions with Drug Resistant Mutants and Wild Type HIV-1 Protease †
Yuan-fang Wang, Irene Weber
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design
D. Decamp, Elaine Meng
The Journal of biological chemistry, 1993
View PDFchevron_right
1 Evaluating the Substrate-Envelope Hypothesis: Structural Analysis of Novel HIV-1 Protease Inhibitors Designed to be Robust against Drug Resistance
Visvaldas Kairys
2016
View PDFchevron_right
Structure-Based Design of Novel HIV-1 Protease Inhibitors to Combat Drug Resistance
Hiroyuki Gatanaga
J. Med. …, 2006
View PDFchevron_right
Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures
Chris Tantillo
Proceedings of the National Academy of Sciences, 1993
View PDFchevron_right
Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors
Roger Tung
Bioorganic & Medicinal Chemistry Letters, 1998
View PDFchevron_right
Design, Synthesis, and Biological and Structural Evaluations of Novel HIV-1 Protease Inhibitors To Combat Drug Resistance
Md Akbar Ali
Journal of Medicinal Chemistry, 2012
View PDFchevron_right
Conformationally constrained HIV-1 protease inhibitors
Joseph Vacca
Bioorganic & Medicinal Chemistry Letters, 1994
View PDFchevron_right
Crystal structure of HIV-1 protease in situ product complex and observation of a low-barrier hydrogen bond between catalytic aspartates
Amit Das
Proceedings of the National Academy of Sciences, 2006
View PDFchevron_right
Inhibitor binding at the protein interface in crystals of a HIV1 protease complex
Renata Collard, Jiří Brynda
Acta Crystallographica Section D-biological Crystallography, 2004
View PDFchevron_right
Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance
Akbar Ali
Journal of virology, 2010
View PDFchevron_right
Optimization of P1-P3 groups in symmetric and asymmetric HIV1 protease inhibitors
bjorn classon
European Journal of Biochemistry, 2003
View PDFchevron_right
The crystal structures at 2.2-A resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations
Michael Minnich
Journal of Biological Chemistry, 1994
View PDFchevron_right
Structure Based Design of Inhibitors of Aspartic Protease of HIV-1
F. Berti, Andrej Jedinák
Letters in Drug Design & Discovery, 2005
View PDFchevron_right